We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > KGaA

News List

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology b3cnewswire
March 16, 2022
A German independent research institute, BioMed X, announces today the start of its new research project ‘Regulatory T Cell...
Merck KGaA, Quris Partner on BioAI Platform for Clinical Safety Prediction contractpharma
February 10, 2022
Merck KGaA to assess Quris’s BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.
BioMed X Institute Successfully Completes Fourth Project in Oncology in Collaboration with Merck KGaA, Darmstadt, Germany B3Cnewswire
November 03, 2021
German independent research institute BioMed X announces today the successful completion of the research project DNA Damage in Cancer (DDC) in collaboration with Merck KGaA, Darmstadt, Germany.
TILT Biotherapeutics to Collaborate with Merck KGaA and Pfizer contractpharma
July 04, 2019
To investigate the combination of oncolytic virus, TILT-123, and anti-PDL1 antibody, avelumab.